Redox International Group Corp. Files 8-K on Equity Sales & Personnel Changes

TL;DR

Redox International Group Corp. sold unregistered equity and changed execs. Watch for dilution.

AI Summary

Redox International Group, Corp. filed an 8-K on June 5, 2024, reporting on unregistered sales of equity securities and changes in its board and officer composition. The company also disclosed other events, with the filing date being August 18, 2025.

Why It Matters

This filing indicates potential dilution from equity sales and changes in corporate leadership, which could impact investor confidence and future strategic direction.

Risk Assessment

Risk Level: medium — Unregistered equity sales can signal financial distress or dilution, while changes in directors and officers can indicate internal shifts or governance issues.

Key Numbers

• 333-255055 — SEC File Number (Identifies the company's filings with the SEC.)
• 98-1578603 — IRS Employer Identification No. (Company's tax identification number.)

Key Players & Entities

• Redox International Group, Corp. (company) — Registrant
• Intorio, Corp. (company) — Former Company Name
• June 5, 2024 (date) — Date of earliest event reported
• August 18, 2025 (date) — Filing Date
• 17875 Von Karman Avenue, Suite 150, Irvine, California 92614 (address) — Business and Mail Address

FAQ

Key Financial Figures

• $0.0001 — f the Company's common stock, par value $0.0001 per share (the "Shares"), to certain se
• $101,700 — the services rendered was approximately $101,700, implying a per share value of approxim
• $0.002 — ying a per share value of approximately $0.002. However, the Company inadvertently rep
• $0.20 — rted the value of per share issuance as $0.20 rather than $0.002 to its transfer agen
• $103,078 — rmer director, advanced an aggregate of $103,078 to us for general working capital, and
• $94,194 — e director, advanced us an aggregate of $94,194 under similar terms. These advances wer

Filing Documents

• redox_8k.htm (8-K) — 35KB
• 0001683168-25-006289.txt ( ) — 196KB
• none-20240605.xsd (EX-101.SCH) — 3KB
• none-20240605_lab.xml (EX-101.LAB) — 33KB
• none-20240605_pre.xml (EX-101.PRE) — 22KB
• redox_8k_htm.xml (XML) — 3KB

02 Unregistered Sales of Equity Securities

ITEM 3.02 Unregistered Sales of Equity Securities. On June 5, 2024, the Board of Directors of Intorio, Corp., which changed its name to Redox International Group, Corp., (the "Company") on March 10, 2025, approved the issuance of an aggregate of 50,850,000 shares of the Company's common stock, par value $0.0001 per share (the "Shares"), to certain service providers in consideration for services rendered to the Company due to the Company's inability to pay in cash. The aggregate fair value of the services rendered was approximately $101,700, implying a per share value of approximately $0.002. However, the Company inadvertently reported the value of per share issuance as $0.20 rather than $0.002 to its transfer agent. The Board of Directors acknowledged the error and adopted a resolution correcting the valuation. No financial statements were issued with the incorrect amount, and the Board has notified the transfer agent to correct the error in their records and memorialized it in a resolution. Accordingly, no restatement of prior financial statements was necessary. The Shares were issued pursuant to the exemption from registration provided by Regulation S (for non-U.S. persons) and Section 4(a)(2) (for accredited U.S. investors) of the Securities Act of 1933, as amended, as transactions not involving a public offering. The recipients of the Shares are either non-U.S. persons or accredited investors, and no general solicitation was used in connection with the issuance. The recipients consisted of consultants and advisors who provided strategic, legal, and business development services. The Shares are subject to any applicable restrictions on transfer under U.S. securities laws. The Company did not pay any underwriters, brokers, or placement agents in connection with the issuance. Between September 2024 and January 2025, certain affiliates of the Company—namely Dr. Han-Wen Ou and Mr. Hsun-Chih Lee—resold an aggregate of 1,725,000 restricted shares of common stock i

02 Departure of Directors or Certain

ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Effective March 6, 2025, Dr. Han-Wen Ou resigned from his position as the sole director of Redox International Group, Corp. (the "Company"). Dr. Ou's resignation was not the result of any disagreement with the Company on any matter relating to its operations, policies, or practices. Dr. Ou will continue to serve as our Chief Executive Officer. On the same date, and prior to his resignation, Dr. Ou appointed Mr. Hsun-Chih Lee to serve as a director of the Company to fill the vacancy that would be created by Dr. Ou's resignation. Mr. Lee had previously served as an officer and affiliate of the Company and brings significant operational and industry experience. Mr. Lee's appointment was made pursuant to the Company's bylaws and does not involve any arrangement or understanding with any other person. The Company thanks Dr. Ou for his service and contributions and welcomes Mr. Lee to the Board. In the ordinary course of business, the Company has received advances from related parties to fund working capital needs and operating expenses. These advances are non-interest bearing, unsecured, and payable upon demand, and no formal agreements were executed in connection with such transactions. From May 16, 2024 through August 15, 2025, Dr. Han-Wen Ou, our current chief executive officer and former director, advanced an aggregate of $103,078 to us for general working capital, and operational funding. These advances were made without any expectation of interest or equity conversion and are classified as "Due to Related Parties" on the Company's balance sheet. In addition, from May 16, 2024 through August 18, 2025, Mr. Hsun-Chih Lee, our current sole director, advanced us an aggregate of $94,194 under similar terms. These advances were likewise unsecured, non-interest bearing, and repayable upon demand. There are no o

01 Other Events

ITEM 8.01 Other Events. On July 7, 2025, the Board of Directors of the Company, acting by written consent, adopted a resolution acknowledging that unregistered resales of common stock by its affiliates may have violated Regulation S resale restrictions. The Board further authorized: The submission of rescission offers by the affiliates; A review of the Company's compliance policies and transfer agent oversight procedures; Coordination with securities counsel to determine any required disclosures in SEC filings; and The preparation of a subsequent events footnote for its audited financial statements, if applicable. 3

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. REDOX INTERNATIONAL GROUP, CORP. Dated: August 18, 2025 By: /s/ Han-Wen Ou Name: Han-Wen Ou Title: Chief Executive Officer 4

View Full Filing

View this 8-K filing on SEC EDGAR